Affiliations 

  • 1 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
  • 2 Department of Cardiovascular Medicine, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • 3 Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia
  • 4 Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan
  • 5 Department of Cardiovascular Medicine, Shanghai Key Lab of Hypertension, Shanghai Institute of Hypertension, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • 6 Punjab Medical Center, Lahore, Pakistan
  • 7 Faculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea
  • 8 Departement of Neurology. School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 9 Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 10 Department of Internal Medicine, National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan
  • 11 Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 12 Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Vietnam
  • 13 Department of Preventive and Community Medicine and Research Institute for Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines
  • 14 Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 15 Divisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 16 Section of Cardiology, Department of Medicine, Medical Center Manila, Manila, Philippines
  • 17 Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia
  • 18 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea
  • 19 Fortis Hospitals, Chennai, Tamil Nadu, India
  • 20 Department of General Medicine, Tan Tock Seng Hospital, Singapore
  • 21 Division of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore
  • 22 JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong
  • 23 Department of Physiology, King George's Medical University, Lucknow, India
J Clin Hypertens (Greenwich), 2022 Sep;24(9):1112-1120.
PMID: 36196465 DOI: 10.1111/jch.14555

Abstract

Morning hypertension is an important clinical target in the management of hypertension for perfect 24-h blood pressure (BP) control. Morning hypertension is generally categorized into two types: "morning surge" type and "sustained nocturnal and morning hypertension" type. The "morning surge" type is characterized by an exaggerated morning blood pressure surge (MBPS), and the "sustained nocturnal and morning hypertension" type with continuous hypertension from nighttime to morning (non-dipper/riser type). They can be detected by home and ambulatory blood pressure measurements (HBPM and ABPM). These two forms of morning hypertension both increase the risk of cardiovascular and renal diseases, but may occur via different pathogenic mechanisms and are associated with different conditions. Morning hypertension should be treated to achieve a morning BP level of 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.